Towards Healthcare
Compounding Chemotherapy Market Expands USD 9.97 Bn by 2034

Compounding Chemotherapy Market Forecast 2025 Personalized Care & Rare Cancers Fuel Expansion

Market insights predict, the compounding chemotherapy industry is expected to grow from USD 5.34 billion in 2024 to USD 9.97 billion by 2034, driven by a CAGR of 6.44%.The compounding chemotherapy market is growing due to rising cases of cancer and growing research in developing compound pharmacy. North America dominated the market in 2024 due to the rising need for personalized medicine and CRISPR therapy.

Content

  • Insight Code: 5889
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The compounding chemotherapy market is projected to reach USD 9.97 billion by 2034, growing at a CAGR of 6.44% from 2024 to 2034.

North America is currently leading the compounding chemotherapy market due to rising cancer research and advancements in personalized treatments for cancer.

The compounding chemotherapy market includes six segments such as by compounding type, by drug type, by cancer type, by compounding setting, by end-user, and by region.

Key trends include rising research on CRISPR-gene therapy, growing prevalence of cancer, and government initiatives.

Chemotherapy medications can be precisely measured and mixed using automated compounding equipment that follow pre-programmed formulae. This guarantees that patients receive the right amount of medication by lowering the possibility of human mistakes in dose calculations.

In a sterile setting, patient dosages are prepared for administration, and the compounding robot is positioned beneath a sterile laminar flow hood. A patent-pending closed system keeps the pollution at bay.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions